What is the recommended evaluation and treatment approach for trigger finger (stenosing flexor tenosynovitis)?

Trigger Finger (Stenosing Flexor Tenosynovitis)

Overview and Diagnosis

Trigger finger is caused by inflammation and narrowing of the A1 pulley, creating a size mismatch between the flexor tendon and pulley, resulting in painful clicking, catching, locking, and loss of motion of the affected finger. 1, 2

Clinical Presentation

• Painful snapping or locking when flexing the finger, sometimes requiring manual reduction in severe cases 3, 4
• More common in women in the fifth to sixth decade of life and significantly more prevalent in diabetic patients 1
• Affects 2-3.6% of the general population, with higher incidence in manual laborers and those performing repetitive hand activities 5
• Palpable nodule may be present at the A1 pulley level 4

Diagnostic Evaluation

• Clinical diagnosis is straightforward based on history of clicking or locking 1
• Ultrasound imaging can confirm tendon pathology, tenosynovitis, and assess A1 pulley thickening when diagnosis is uncertain 6, 7
• Must exclude fracture, tumor, or other traumatic soft tissue injuries 1
• Functional grading using Quinnell classification helps guide treatment decisions 3, 5

Treatment Algorithm

First-Line Conservative Management

Begin with splinting and activity modification for mild to moderate cases (Quinnell grade 1-2). 3, 8

• Splinting: Immobilize the affected finger in extension, particularly the metacarpophalangeal joint 3, 8
• Activity modification: Reduce repetitive gripping and grasping activities 3
• Duration: Trial conservative therapy for 6-12 weeks before advancing treatment 3

Second-Line: Corticosteroid Injection

For persistent symptoms after 6-12 weeks of splinting or for moderate severity (Quinnell grade 2-3), proceed with corticosteroid injection. 3, 8

• Technique: Inject at the A1 pulley level, can be performed with or without ultrasound guidance 3, 7
• Effectiveness: Provides significant pain relief and functional improvement in many patients 3, 8
• Caution in diabetics: Less responsive to conservative measures including injections; may require earlier surgical consideration 2
• Can combine corticosteroid injection with continued splinting 3

Emerging Conservative Options

Extracorporeal shock wave therapy (ESWT) and electroacupuncture may be considered for patients seeking non-invasive alternatives before surgery. 7, 4

• ESWT: Growing evidence as a non-invasive treatment option 7
• Electroacupuncture: Case reports show resolution with 4 treatments using 10 Hz stimulation at the A1 pulley 4

Surgical Intervention

Reserve surgery for patients who fail 3-6 months of conservative therapy or those with severe locking (Quinnell grade 4). 3, 8, 2

Surgical Options:

Open A1 pulley release remains the gold standard with highest success rates. 8, 2

• Open release: Direct visualization, complete A1 pulley division 8, 2
• Ultrasound-guided percutaneous release: Shows improved QDASH scores at 1 month and faster return to normal activities (13.78 days earlier) compared to open surgery 5
• Percutaneous release: Minimally invasive alternative with comparable outcomes 8, 2

Additional Surgical Considerations:

• If triggering persists after A1 release: Consider excision of one slip of flexor digitorum superficialis 8
• Rheumatoid arthritis patients: Require tenosynovectomy instead of simple A1 pulley release 2
• Pediatric trigger thumb: Treat with open A1 pulley release 8
• Pediatric trigger finger: May require flexor digitorum superficialis slip excision if triggering persists after A1 release 8

Important Clinical Pitfalls

• Diabetic patients have poorer response to conservative treatment and may benefit from earlier surgical referral 2
• Complications of surgery are rare but include bowstringing, digital nerve injury, and persistent triggering 2
• Underlying systemic conditions: Consider screening for hypothyroidism or Hashimoto's thyroiditis in patients with atypical or treatment-resistant presentations 9
• Multiple digit involvement: Should prompt evaluation for rheumatologic disease 10

Expected Outcomes

• Most patients (approximately 80%) recover fully within 3-6 months with appropriate treatment 10
• Surgical success rates are high with both open and ultrasound-guided techniques 5
• Ultrasound-guided release offers advantages of faster return to activities while maintaining comparable efficacy to open surgery 5